p38γ MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Ho, Richard C ^a   Alcazar, Oscar ^a   Fujii, Nobuharu ^a   Hirshman, Michael F ^a   Goodyear, Laurie J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Exercise; GLUT1; GLUT4; Mitogen activated protein kinase

Indexed keywords

2,4 DINITROPHENOL; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; TRITIUM; UNCLASSIFIED DRUG; ISOENZYME; MAP2K6 PROTEIN, HUMAN; MAP2K6 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; PROTEIN KINASE (CALCIUM,CALMODULIN); UNCOUPLING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPORATION; EXERCISE; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; IMMUNOBLOTTING; MUSCLE CONTRACTION; MYOBLAST; MYOTUBE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; ANIMAL; CELL LINE; GENETIC TRANSFECTION; GENETICS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; MOLECULAR GENETICS; MOUSE; MUSCLE CELL; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

2,4-DINITROPHENOL; ANIMALS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; DEOXYGLUCOSE; GLUCOSE; HUMANS; INJECTIONS, INTRAMUSCULAR; ISOENZYMES; MAP KINASE KINASE 6; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSFECTION; UNCOUPLING AGENTS;

EID: 0942298232     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00563.2003     Document Type: Article

References (51)

1. Adams ME, Mueller HA, and Forehner SC. In vivo requirement of the a-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol 155: 113-122, 2001.
2. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
3. Aihara H and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16: 867-870, 1998.
4. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, and Goodyear LJ. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest 99: 1251-1257, 1997.
5. Barros LF, Barnes K, Ingram JC, Castro J, Porras OH, and Baldwin SA. Hyperosmotic shock induces both activation and translocation of glucose transporters in mammalian cells. Pflügers Arch 442: 614-621, 2001.
6. Boppart MD, Asp S, Wojtaszewski JF, Fielding RA, Mohr T, and Goodyear LJ. Marathon running transiently increases c-Jun NH2-terminal kinase and p38 activities in human skeletal muscle. J Physiol 526: 663-669, 2000.
7. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Marchand-Brustel Y, Tanti JF, and Vidal H. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52: 1319-1325, 2003.
8. Carlson CJ, Koterski S, Sciotti RJ, Poccard GB, and Rondinone CM. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52: 634-641, 2003.
9. Clerk A and Sugden PH. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/ JNKs). FEBS Lett 426: 93-96, 1998.
10. Court NW, dos Remedios CG, Cordell J, and Bogoyevitch MA. Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 34: 413-426, 2002.
11. Cuenda A, Cohen P, Buee-Scherrer V, and Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16: 295-305, 1997.
12. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, and Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 76: 148-155, 1985.
13. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, and Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981.
14. Enslen H, Raingeaud J, and Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273: 1741-1748, 1998.
15. Fujii N, Boppart MD, Dufresne SD, Jozsi AC, Crowley PF, Hirshman MF, and Goodyear LJ. Overexpression of JNK in skeletal muscle does not alter glycogen synthase activity. Diabetes 50, Suppl 2: A276, 2001.
16. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onish Y, Ono H, Abe M, Shojima N, Fukushima Y, Kikuchi M, Oka Y, and Asano T. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 17: 487-497, 2003.
17. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, and Asano T. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 276: 19800-19806, 2001.
18. Goedert M, Cuenda A, Craxton M, Jakes R, and Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J 16: 3563-3571, 1997.
19. Goodyear LJ, Chung PY, Sherwood D, Dufresne SD, and Moller DE. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol Endocrinol Metab 271: E403-E408, 1996.
20. Gulli G, Ferrannini E, Stern M, Haffner S, and DeFronzo RA. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41: 1575-1586, 1992.
21. Han J, Lee JD, Jiang Y, Li Z, Feng L, and Ulevitch RJ. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271: 2886-2891, 1996.
22. Hasegawa M, Cuenda A, Spillantini MG, Thomas GM, Buee-Scherrer V, Cohen P, and Goedert M. Stress-activated protein kinase-3 interacts with the PDZ domain of α1-syntrophin. A mechanism for specific substrate recognition. J Biol Chem 274: 12626-12631, 1999.
23. Hayashi T, Hirshman MF, Dufresne SD, and Goodyear LJ. Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am J Physiol Cell Physiol 277: C701-C707, 1999.
24. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
25. Huang M, Wang Y, Collins M, Gu JJ, Mitchell BS, and Graves LM. Inhibition of nucleoside transport by p38 MAPK inhibitors. J Biol Chem 277: 28364-28367, 2002.
26. James DE, Jenkins AB, and Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol Endocrinol Metab 248: E567-E574, 1985.
27. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, and Han J. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem 271: 17920-17926, 1996.
28. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Di Padova F, Ulevitch RJ, and Han J. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J Biol Chem 272: 30122-30128, 1997.
29. Kameya S, Miyagoe Y, Nonaka I, Ikemoto T, Endo M, Hanaoka K, Nabeshima Y, and Takeda S. α1-Syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 274: 2193-2200, 1999.
30. Kayali AG, Austin DA, and Webster NJ. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes 49: 1783-1793, 2000.
31. Koistinen HA, Chibalin AV, and Zierath JR. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from type 2 diabetic patients. Diabetologia 2003.
32. Lali FV, Hunt AE, Turner SJ, and Foxwell BM. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem 275: 7395-7402, 2000.
33. Lechner C, Zahalka MA, Giot JF, Moller NP, and Ullrich A. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 93: 4355-4359, 1996.
34. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, and Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
35. Li Z, Jiang Y, Ulevitch RJ, and Han J. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228: 334-340, 1996.
36. Liang JP, Huang R, Robinson D, and Badwey JA. Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade. J Immunol 163: 4527-4536, 1999.
37. Miyazaki J, Takaki S, Araki K, Tashiro F, Tominaga A, Takatsu K, and Yamamura K. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5. Gene 79: 269-277, 1989.
38. Niwa H, Yamamura K, and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991.
39. Okabe M, Ikawa M, Kominami K, Nakanishi T, and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 407: 313-319, 1997.
40. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, and Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required fibroblast proliferation. Proc Natl Acad Sci USA 90: 8319-8323, 1993.
41. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, and Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995.
42. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, and Davis RJ. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255, 1996.
43. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486, 1995.
44. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, and Zierath JR. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. J Biol. Chem 275: 1457-1462, 2000.
45. Somwar R, Kim DY, Sweeney G, Huang C, Niu W, Lador C, Ramlal T, and Klip A. GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 359: 639-649, 2001.
46. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, and Klip A. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 277: 50386-50395, 2002.
47. Somwar R, Perreault M, Kapur S, Taha C, Sweeney G, Ramlal T, Kim DY, Keen J, Cote CH, Klip A, and Marette A. Activation of p38 mitogen-activated protein kinase-α and -β by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes 49: 1794-1800, 2000.
48. Stein B, Yang MX, Young DB, Janknecht R, Hunter T, Murray BW, and Barbosa MS. p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 272: 19509-19517, 1997.
49. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999.
50. Tokui M, Takei I, Tashiro F, Shimada A, Kasuga A, Ishii M, Ishii T, Takatsu K, Saruta T, and Miyazaki J. Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. Biochem Biophys Res Commun 233: 527-531, 1997.
51. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N, Lichenstein HS, Zukowsk M, and Yao Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272: 23668-23674, 1997.